Alina Schidlitzki
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy.
Journal: Journal of Parkinson's disease
Published: February 20, 2025
Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-Synuclein.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 17, 2022
Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy.
Journal: Neurobiology of disease
Published: January 06, 2021
Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms.
Journal: Frontiers in cell and developmental biology
Published: August 24, 2020
Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy.
Journal: Neurobiology of disease
Published: July 13, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.
Journal: Neuropharmacology
Published: June 17, 2020
A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies.
Journal: Epilepsia
Published: September 27, 2019
Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model.
Journal: Neuropharmacology
Published: August 07, 2019
Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy.
Journal: Neurobiology of disease
Published: August 06, 2019
Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice.
Journal: Epilepsy research
Published: November 20, 2018
A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy.
Journal: Scientific reports
Published: May 22, 2017
The intrahippocampal kainate mouse model of mesial temporal lobe epilepsy: Lack of electrographic seizure-like events in sham controls.
Journal: Epilepsia open
Published: January 24, 2017
Last Updated: 09/26/2026